Introduction
under evaluation.
The Registry has at its disposal a permanent office, based
The incidence and prevalence of end-stage renal failure in London, with permanent staff. This office is run by a ( ESRF ) continue to increase despite the many Managing Director and should issue and collect all Centre advancements achieved in general nephrology. This and Patient Questionnaires, in order to establish the situation is due mainly to ageing of the general popula-European data. There is a Scientific Advisory Board (SAB) composed of expert colleagues from various fields (nephrolotion in all countries of Western Europe. Currently, life gists, biostatisticians, epidemiologists, etc.) nominated for 3 expectancy is commonly over 80 years for females and years (with a possible extension for an additional 3 years).
over 74 years for males; the gender difference is at
Its role is to propose specific scientific studies in using the least 6 years.
accumulated data in the Registry.
Here, we analysed the data concerning patients aged 60 years and over during the year 1995, who had been
The 1995 Centre Questionnaire data treated for ESRF.
For this study, we used all of the information obtained in 1995 through the Centre Questionnaire. These data were The ERA Registry demography and the bicompartmental model for ESRF treatment either by dialysis (any type and/or modalities) or The goal of the Registry is to collect, on a yearly basis, renal transplantation (any modalities). Basically, the new information on all treated ESRF patients in European and patients (Ni, i for input) are entering the compartment (Ns; Mediterranean countries. This includes the new patients s for stock) while patients are leaving because of death (No, starting their first renal replacement therapy (RRT ) in the o for output). This dynamic allows the calculation of incidreference year, the ESRF patients who died during the year ence, prevalence with the different flows and transfers, and regardless of the date of start of first treatment, and the alive also the rate of expansion of this population. More precisely, patients currently in treatment for ESRF regardless of the if P corresponds to the general population served by the type and modalities of treatment (haemodialysis, peritoneal centre, the incidence of new patients is Ni/P, the prevalence dialysis or renal transplantation). In addition, there is a of treated ESRF is Ns/P and the incidence of death is No/P. longitudinal study from the first RRT to the last or current We can then derive the net increase per year (Ni-No)/P. The treatment, with all switches indicated. overall response rate was 64% for this questionnaire. The procedure used by the Registry to collect the data is based on two different questionnaires. (i) The Centre
Subjects and methods

The 1995 Patient Questionnaire
Questionnaire collects global data on the activity of the centre during the year. It allows the collection of epidemiologThe Patient Questionnaires were used only to calculate the ical data with at most 1 year delay. It is currently paper age distribution of patients at time of first RRT, at time of data, but a specific software called Nephrology Center death, and for alive updated patients at December 31, 1995. Questionnaire (NCQ) will be released in 1998. (ii) The
The data used were paper Patient Questionnaires returned Patient Questionnaire collects basic information on all ESRF to the office. The number of patients analysed with valid patients. The mandatory items were designed by a specific data is only 46 677. To simplify, the age stratification was specialized task force. It is currently available on paper but done in four categories: under 15; from 15 to 39; from 40 to also as specific software called Mac Pas II, developed by 59; and 60 years and over. This last category corresponds to Shalom Mendel and co-workers at the University of Tel the so called 'elderly patients', but was stratified further into three groups: from 60 to 69; 70 to 79; and 80 years and over, subpopulation. for HD and PD. The incidence of new ESRF patients (Ni/P) was 91 per million population (pmp) for all the Registry (based on The ESRF patient deaths in 1995 a 64% response rate to the Centre Questionnaire) ( Table 1 ). The population really surveyed was 418 mil-The incidence of ESRF deaths (No/P) was 48 pmp for lion. The data for Western countries ranged from 163 in the whole Registry, with 80 pmp in Italy, 58 pmp in Germany (the highest figure) to 87 in the UK, with 112 France and 53 pmp in The Netherlands. The death in France and 82 in The Netherlands (100% response rate ( Ko) was very close in each country: mean of rate). The mean value for all the Registry was 91 pmp. 11% (of the ESRF pool ) with a range from 8 to 12% For Italy, this gives a theoretical number of 7576 new ( Table 1) . patients in 1995. The mean rate of new patients ( Ki)
The respective mean and median age at death (Table 3 ) was 21% (of the ESRF pool ) overall, with a range from were 68.9 and 71 years for Italy as compared with 67.2 mean 16 to 22% with 17% in Italy. and 69 overall. The age distribution at death demonstrated The age distribution of these new patients is given that before age 40 years, death is a rare event: at time of in Table 2 . The mean and median age were respectively death, only 5% were aged 15-39, as compared with 72% 56.8 and 60 years overall as compared with 60.0 and for the subgroup 60+, and these values were respectively 64 years in Italy. The proportion of patients 60 years 3 and 81% for Italy. Fifty three percent of patients dying or older (60+) at the time of first RRT was 61% in were aged Á70 years. Italy as compared with 52% overall. The proportion of patients 70 years or older was 35% in Italy vs The pool ('stock') of alive ESRF patients on December 27% overall.
31, 1995 The first RRT treatment in 1995 was haemodialysis
The point prevalence (Ns/P) of ESRF was the highest (HD) in 83% of the patients, peritoneal dialysis (PD) in Italy, with 773 pmp as compared with 439 for the in 15.5% and only 1.5% had preemptive renal transwhole Registry and 511 for The Netherlands ( Table 1) . The mean, the median and the distribution of age of patients at time of first RRT is given for the whole Registry and some Western The mean, the median and the distribution of patients age at time of death during 1995. countries. Table 4 . Age distribution of alive treated ESRF patients on plantation ( Tx). The dialysed pool ( Table 5) Conversely, the Tx pool ( Table 6 ) with a func- 
Discussion
The other epidemiological data for 1995
The bicompartmental model produced valuable The data collected can always be questioned because we did not reach a 100% response rate. Nevertheless, information concerning dialysis (D) vs renal trans- 
